Chang SY - Search Results

1

An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein.

Yoon A, Yi KS, Chang SY, Kim SH, Song M, Choi JA, Bourgeois M, Hossain MJ, Chen LM, Donis RO, Kim H, Lee Y, Hwang DB, Min JY, Chang SJ, Chung J. Yoon A, et al. Among authors: chang sj, chang sy. PLoS One. 2015 Oct 29;10(10):e0141312. doi: 10.1371/journal.pone.0141312. eCollection 2015. PLoS One. 2015. PMID: 26512723 Free PMC article.

2

A natural component from Euphorbia humifusa Willd displays novel, broad-spectrum anti-influenza activity by blocking nuclear export of viral ribonucleoprotein.

Chang SY, Park JH, Kim YH, Kang JS, Min JY. Chang SY, et al. Biochem Biophys Res Commun. 2016 Mar 4;471(2):282-9. doi: 10.1016/j.bbrc.2016.01.123. Epub 2016 Feb 3. Biochem Biophys Res Commun. 2016. PMID: 26850850

3

Identification of pyrrolo[3,2-c]pyridin-4-amine compounds as a new class of entry inhibitors against influenza viruses in vitro.

Chang SY, Cruz DJ, Ko Y, Min JY. Chang SY, et al. Biochem Biophys Res Commun. 2016 Sep 30;478(4):1594-601. doi: 10.1016/j.bbrc.2016.08.162. Epub 2016 Aug 29. Biochem Biophys Res Commun. 2016. PMID: 27586275

4

Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody.

Kim SI, Kim S, Shim JM, Lee HJ, Chang SY, Park S, Min JY, Park WB, Oh MD, Kim S, Chung J. Kim SI, et al. Among authors: chang sy. Biochem Biophys Res Commun. 2021 Mar 19;545:33-39. doi: 10.1016/j.bbrc.2021.01.075. Epub 2021 Jan 31. Biochem Biophys Res Commun. 2021. PMID: 33535104 Free article.

5

A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin.

Yu F, Song H, Wu Y, Chang SY, Wang L, Li W, Hong B, Xia S, Wang C, Khurana S, Feng Y, Wang Y, Sun Z, He B, Hou D, Manischewitz J, King LR, Song Y, Min JY, Golding H, Ji X, Lu L, Jiang S, Dimitrov DS, Ying T. Yu F, et al. Among authors: chang sy. Cell Host Microbe. 2017 Oct 11;22(4):471-483.e5. doi: 10.1016/j.chom.2017.08.011. Epub 2017 Sep 28. Cell Host Microbe. 2017. PMID: 28966056 Free PMC article.

6

Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody.

Kim SI, Kim S, Kim J, Chang SY, Shim JM, Jin J, Lim C, Baek S, Min JY, Park WB, Oh MD, Kim S, Chung J. Kim SI, et al. Among authors: chang sy. Int J Mol Sci. 2019 Oct 12;20(20):5073. doi: 10.3390/ijms20205073. Int J Mol Sci. 2019. PMID: 31614869 Free PMC article.

7

Extensive Viable Middle East Respiratory Syndrome (MERS) Coronavirus Contamination in Air and Surrounding Environment in MERS Isolation Wards.

Kim SH, Chang SY, Sung M, Park JH, Bin Kim H, Lee H, Choi JP, Choi WS, Min JY. Kim SH, et al. Among authors: chang sy. Clin Infect Dis. 2016 Aug 1;63(3):363-9. doi: 10.1093/cid/ciw239. Epub 2016 Apr 18. Clin Infect Dis. 2016. PMID: 27090992 Free PMC article.

8

Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins.

Bulanova D, Ianevski A, Bugai A, Akimov Y, Kuivanen S, Paavilainen H, Kakkola L, Nandania J, Turunen L, Ohman T, Ala-Hongisto H, Pesonen HM, Kuisma MS, Honkimaa A, Walton EL, Oksenych V, Lorey MB, Guschin D, Shim J, Kim J, Than TT, Chang SY, Hukkanen V, Kulesskiy E, Marjomaki VS, Julkunen I, Nyman TA, Matikainen S, Saarela JS, Sane F, Hober D, Gabriel G, De Brabander JK, Martikainen M, Windisch MP, Min JY, Bruzzone R, Aittokallio T, Vähä-Koskela M, Vapalahti O, Pulk A, Velagapudi V, Kainov DE. Bulanova D, et al. Among authors: chang sy. Viruses. 2017 Sep 25;9(10):271. doi: 10.3390/v9100271. Viruses. 2017. PMID: 28946654 Free PMC article.

9

Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19.

Ko M, Chang SY, Byun SY, Ianevski A, Choi I, Pham Hung d'Alexandry d'Orengiani AL, Ravlo E, Wang W, Bjørås M, Kainov DE, Shum D, Min JY, Windisch MP. Ko M, et al. Among authors: chang sy. Viruses. 2021 Apr 9;13(4):651. doi: 10.3390/v13040651. Viruses. 2021. PMID: 33918958 Free PMC article.

10

Mycoplasma genitalium infection and resistance-associated mutations to macrolides and fluoroquinolones among high-risk patients in Taiwan.

Tsai MJ, Sun HY, Su LH, Lin KY, Liu WD, Huang YS, Chen GJ, Su YC, Liu WC, Chang SY, Hung CC. Tsai MJ, et al. Among authors: chang sy. J Microbiol Immunol Infect. 2024 May 11:S1684-1182(24)00081-1. doi: 10.1016/j.jmii.2024.05.004. Online ahead of print. J Microbiol Immunol Infect. 2024. PMID: 38777653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,639 results

Search Page